{"id":20606,"date":"2025-11-02T19:32:46","date_gmt":"2025-11-02T18:32:46","guid":{"rendered":"https:\/\/europa-peptide.com\/?post_type=product&#038;p=20606"},"modified":"2026-05-21T22:50:49","modified_gmt":"2026-05-21T20:50:49","slug":"cagrilintide-10mg","status":"publish","type":"product","link":"https:\/\/europa-peptide.com\/fi\/shop\/cagrilintide-10mg\/","title":{"rendered":"Cagrilintide 10mg"},"content":{"rendered":"<h3 data-start=\"145\" data-end=\"228\"><strong data-start=\"149\" data-end=\"228\">Cagrilintide 10 mg - Amylin analoginen peptidi ruokahalun ja painon s\u00e4\u00e4telyyn<\/strong><\/h3>\n<p data-start=\"230\" data-end=\"454\"><strong data-start=\"230\" data-end=\"246\">Koostumus:<\/strong> 10 mg Cagrilintide (lyofilisoitu peptidijauhe)<br data-start=\"294\" data-end=\"297\" \/><strong data-start=\"297\" data-end=\"310\">Kategoria:<\/strong> Peptidi<br data-start=\"318\" data-end=\"321\" \/><strong data-start=\"321\" data-end=\"330\">Lomake:<\/strong> Injektiopullo, jossa on kylm\u00e4kuivattua jauhetta<br data-start=\"360\" data-end=\"363\" \/><strong data-start=\"363\" data-end=\"382\">Hallinto:<\/strong> Ihonalainen injektio sen j\u00e4lkeen, kun se on saatettu bakteriostaattiseen veteen<\/p>\n<hr data-start=\"456\" data-end=\"459\" \/>\n<h3 data-start=\"461\" data-end=\"490\"><strong data-start=\"465\" data-end=\"490\">Mik\u00e4 on Cagrilintide?<\/strong><\/h3>\n<p data-start=\"492\" data-end=\"819\">Kagrilintidi on seuraavan sukupolven pitk\u00e4vaikutteinen l\u00e4\u00e4kemyrkky. <strong data-start=\"539\" data-end=\"574\">amyliinireseptorin agonistinen peptidi<\/strong> joka j\u00e4ljittelee ja tehostaa seuraavien fysiologisten vaikutusten vaikutusta <strong data-start=\"629\" data-end=\"639\">amyliini<\/strong>, hormoni, jota haiman \u03b2-solut eritt\u00e4v\u00e4t yhdess\u00e4 insuliinin kanssa.<br data-start=\"698\" data-end=\"701\" \/>Sill\u00e4 on ratkaiseva merkitys <strong data-start=\"728\" data-end=\"816\">ruokahalun tukahduttaminen, viiv\u00e4stynyt mahalaukun tyhjeneminen ja kehon painon pitk\u00e4aikainen s\u00e4\u00e4tely.<\/strong>.<\/p>\n<p data-start=\"821\" data-end=\"1064\">Kagrilintiidi\u00e4 on tutkittu laajasti sek\u00e4 monoterapiana ett\u00e4 yhdess\u00e4 <strong data-start=\"892\" data-end=\"936\">yhdistelm\u00e4 GLP-1-reseptoriagonistien kanssa<\/strong>(kuten semaglutidi tai tiirzepatidi), jotka osoittavat, ett\u00e4 <strong data-start=\"983\" data-end=\"1006\">synergistiset vaikutukset<\/strong> v\u00e4hent\u00e4\u00e4 ruoan saantia ja edist\u00e4\u00e4 kest\u00e4v\u00e4\u00e4 rasvan menetyst\u00e4.<\/p>\n<p data-start=\"1066\" data-end=\"1161\">\u27a1\ufe0f <strong data-start=\"1069\" data-end=\"1161\">Ihanteellinen ruokahalun hallintaan, kyll\u00e4isyystutkimuksiin ja pitk\u00e4lle kehitettyihin aineenvaihdunnan modulaatiotutkimuksiin.<\/strong><\/p>\n<hr data-start=\"1163\" data-end=\"1166\" \/>\n<h3 data-start=\"1168\" data-end=\"1197\"><strong data-start=\"1172\" data-end=\"1197\">T\u00e4rkeimm\u00e4t tutkimustulokset<\/strong><\/h3>\n<p data-start=\"1199\" data-end=\"1349\"><strong data-start=\"1199\" data-end=\"1230\">Amylin-reseptorin aktivointi:<\/strong><br data-start=\"1230\" data-end=\"1233\" \/>Amyliini- ja kalsitoniinireseptorikompleksien selektiivinen aktivointi, joka lis\u00e4\u00e4 kyll\u00e4isyytt\u00e4 ja viiv\u00e4stytt\u00e4\u00e4 mahalaukun tyhjenemist\u00e4.<\/p>\n<p data-start=\"1351\" data-end=\"1484\"><strong data-start=\"1351\" data-end=\"1381\">Ruokahalu ja kalorien saanti:<\/strong><br data-start=\"1381\" data-end=\"1384\" \/>V\u00e4hent\u00e4\u00e4 voimakkaasti n\u00e4lk\u00e4signaaleja ja kokonaisenergiansaantia keskus- ja \u00e4\u00e4reismekanismien kautta.<\/p>\n<p data-start=\"1486\" data-end=\"1609\"><strong data-start=\"1486\" data-end=\"1513\">Kehon painon s\u00e4\u00e4tely:<\/strong><br data-start=\"1513\" data-end=\"1516\" \/>Edist\u00e4\u00e4 tasaista ja kest\u00e4v\u00e4\u00e4 painonpudotusta, erityisesti kun sit\u00e4 k\u00e4ytet\u00e4\u00e4n yhdess\u00e4 GLP-1-analogien kanssa.<\/p>\n<p data-start=\"1611\" data-end=\"1721\"><strong data-start=\"1611\" data-end=\"1644\">Glykeeminen ja aineenvaihdunnan hallinta:<\/strong><br data-start=\"1644\" data-end=\"1647\" \/>Tukee parempaa aterianj\u00e4lkeist\u00e4 glukoosinsietokyky\u00e4 ja insuliinin tehokkuutta.<\/p>\n<p data-start=\"1723\" data-end=\"1848\"><strong data-start=\"1723\" data-end=\"1752\">Synergistiset yhdistelm\u00e4t:<\/strong><br data-start=\"1752\" data-end=\"1755\" \/>Tutkitaan usein tutkimuksissa GLP-1-agonistien kanssa kokonaisvaltaista aineenvaihdunnan hallintaa varten.<\/p>\n<hr data-start=\"1850\" data-end=\"1853\" \/>\n<h3 data-start=\"1855\" data-end=\"1883\"><strong data-start=\"1859\" data-end=\"1883\">Annostus ja k\u00e4ytt\u00f6<\/strong><\/h3>\n<p data-start=\"1885\" data-end=\"1937\">Rekonstruoidaan bakteriostaattisella vedell\u00e4 ennen k\u00e4ytt\u00f6\u00e4.<\/p>\n<p data-start=\"1939\" data-end=\"2042\">Tyypillinen tutkimusalue: <strong data-start=\"1963\" data-end=\"1995\">0,1 - 0,3 mg annosta kohti<\/strong>, ihon alle (tutkimusasetelmasta riippuen).<\/p>\n<p data-start=\"2044\" data-end=\"2117\"><strong data-start=\"2044\" data-end=\"2058\">Taajuus:<\/strong> Kerran viikossa metabolisissa tai ruokahalua s\u00e4\u00e4televiss\u00e4 tutkimuksissa.<\/p>\n<p data-start=\"2119\" data-end=\"2194\">S\u00e4ilyt\u00e4 palautettu liuos j\u00e4\u00e4kaapissa ja k\u00e4yt\u00e4 sis\u00e4ll\u00e4 <strong data-start=\"2180\" data-end=\"2191\">30 p\u00e4iv\u00e4\u00e4<\/strong>.<\/p>\n<hr data-start=\"2196\" data-end=\"2199\" \/>\n<h3 data-start=\"2201\" data-end=\"2229\"><strong data-start=\"2205\" data-end=\"2229\">S\u00e4ilytysohjeet<\/strong><\/h3>\n<ul data-start=\"2231\" data-end=\"2362\">\n<li data-start=\"2231\" data-end=\"2265\">\n<p data-start=\"2233\" data-end=\"2265\">S\u00e4ilyt\u00e4 osoitteessa <strong data-start=\"2242\" data-end=\"2263\">2-8 \u00b0C (36-46 \u00b0F)<\/strong><\/p>\n<\/li>\n<li data-start=\"2266\" data-end=\"2305\">\n<p data-start=\"2268\" data-end=\"2305\">Suojaa <strong data-start=\"2281\" data-end=\"2303\">valo ja kosteus<\/strong><\/p>\n<\/li>\n<li data-start=\"2306\" data-end=\"2327\">\n<p data-start=\"2308\" data-end=\"2327\">Tee <strong data-start=\"2311\" data-end=\"2325\">ei j\u00e4\u00e4dy<\/strong><\/p>\n<\/li>\n<li data-start=\"2328\" data-end=\"2362\">\n<p data-start=\"2330\" data-end=\"2362\">V\u00e4lt\u00e4 l\u00e4mp\u00f6tilan vaihteluita<\/p>\n<\/li>\n<\/ul>\n<hr data-start=\"2364\" data-end=\"2367\" \/>\n<h3 data-start=\"2369\" data-end=\"2401\"><strong data-start=\"2373\" data-end=\"2401\">Miksi valita Cagrilintide?<\/strong><\/h3>\n<p data-start=\"2403\" data-end=\"2761\">Cagrilintidi edustaa <strong data-start=\"2429\" data-end=\"2482\">uusi pitk\u00e4vaikutteisten amyliinianalogipeptidien luokka<\/strong>, joka tarjoaa ainutlaatuisen v\u00e4yl\u00e4n opiskeluun <strong data-start=\"2524\" data-end=\"2579\">kyll\u00e4isyys, kalorikontrolli ja metabolinen homeostaasi.<\/strong>.<br data-start=\"2580\" data-end=\"2583\" \/>Sen <strong data-start=\"2592\" data-end=\"2645\">pidennetty puoliintumisaika ja parempi reseptori-affiniteetti<\/strong>, se tarjoaa kest\u00e4vi\u00e4 fysiologisia vaikutuksia ja arvokkaita n\u00e4kemyksi\u00e4 seuraavan sukupolven painonhallintatutkimukseen.<\/p>\n<p data-start=\"2763\" data-end=\"2876\">Tilaa <strong data-start=\"2769\" data-end=\"2791\">Kagrilintidi 10 mg<\/strong> ja tutkia sen mahdollisuuksia <strong data-start=\"2821\" data-end=\"2876\">kehittyneet ruokahalua ja aineenvaihdunnan s\u00e4\u00e4tely\u00e4 koskevat tutkimukset.<\/strong><\/p>","protected":false},"excerpt":{"rendered":"<p>Cagrilintide 10 mg \u2013 Amylin Analog Peptide for Appetite &amp; Weight Regulation Composition: 10 mg Cagrilintide (lyophilized peptide powder)Category: PeptideForm: Vial with freeze-dried powderAdministration: Subcutaneous injection after reconstitution with bacteriostatic water What is Cagrilintide? Cagrilintide is a next-generation, long-acting amylin receptor agonist peptide that mimics and enhances the physiological actions of amylin, a hormone co-secreted with insulin by pancreatic \u03b2-cells.It plays a crucial role in appetite suppression, delayed gastric emptying, and long-term body weight regulation. Cagrilintide has been extensively studied both as a monotherapy and in combination with GLP-1 receptor agonists(such as Semaglutide or Tirzepatide), showing synergistic effects in reducing food intake and promoting sustained fat loss. \u27a1\ufe0f Ideal for appetite control, satiety research, and advanced metabolic modulation studies. Key Research Findings Amylin Receptor Activation:Selective activation of amylin and calcitonin receptor complexes, enhancing satiety and delaying gastric emptying. Appetite &amp; Caloric Intake:Potently reduces hunger signals and total energy intake through central and peripheral mechanisms. Body Weight Regulation:Promotes steady and durable weight reduction, especially when used alongside GLP-1 analogs. Glycemic &amp; Metabolic Control:Supports improved postprandial glucose tolerance and insulin efficiency. Synergistic Combinations:Frequently explored in research with GLP-1 agonists for comprehensive metabolic management. Dosage &amp; Application Reconstitute with bacteriostatic water before use. Typical research range: 0.1 \u2013 0.3 mg per application, subcutaneously (depending on study design). Frequency: Once weekly in metabolic or appetite-regulation studies. Store the reconstituted solution refrigerated and use within 30 days. Storage Instructions Store at 2\u20138 \u00b0C (36\u201346 \u00b0F) Protect from light and moisture Do not freeze Avoid temperature fluctuations Why Choose Cagrilintide? Cagrilintide represents a novel class of long-acting amylin analog peptides, providing a unique pathway for studying satiety, caloric control, and metabolic homeostasis.With its extended half-life and superior receptor affinity, it offers sustained physiological effects and valuable insights into next-generation weight management research. Order Cagrilintide 10 mg and explore its potential in advanced appetite and metabolic regulation studies.<\/p>","protected":false},"featured_media":20603,"comment_status":"open","ping_status":"closed","template":"","meta":{"_acf_changed":false},"product_brand":[],"product_cat":[17,24,25,27],"product_tag":[],"class_list":["post-20606","product","type-product","status-publish","has-post-thumbnail","product_cat-all-products","product_cat-glp-1andmultiagonist","product_cat-metabolismandweightmanagement","product_cat-peptidesandresearchdrugs","entry","has-media","first","instock","shipping-taxable","purchasable","product-type-simple"],"acf":[],"aioseo_notices":[],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/europa-peptide.com\/fi\/wp-json\/wp\/v2\/product\/20606","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/europa-peptide.com\/fi\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/europa-peptide.com\/fi\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/europa-peptide.com\/fi\/wp-json\/wp\/v2\/comments?post=20606"}],"version-history":[{"count":2,"href":"https:\/\/europa-peptide.com\/fi\/wp-json\/wp\/v2\/product\/20606\/revisions"}],"predecessor-version":[{"id":47619,"href":"https:\/\/europa-peptide.com\/fi\/wp-json\/wp\/v2\/product\/20606\/revisions\/47619"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/europa-peptide.com\/fi\/wp-json\/wp\/v2\/media\/20603"}],"wp:attachment":[{"href":"https:\/\/europa-peptide.com\/fi\/wp-json\/wp\/v2\/media?parent=20606"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/europa-peptide.com\/fi\/wp-json\/wp\/v2\/product_brand?post=20606"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/europa-peptide.com\/fi\/wp-json\/wp\/v2\/product_cat?post=20606"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/europa-peptide.com\/fi\/wp-json\/wp\/v2\/product_tag?post=20606"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}